Patients facing a rare disease diagnosis often find that participation in a clinical trial is the only course of treatment available to them. Selecting the right clinical trial payment option to reimburse patients for their participation is critical to improving access, enrollment, and retention in rare disease clinical trials.
In the Fall issue of Clinical Researcher, Scott Gray, CEO discusses how cross-border travel creates significant complexity for trial sponsors and clinical research organizations (CROs), who must contend with complicated travel logistics, participant and family unease, international regulatory compliance, and more. Although many of these challenges have been brought to light in recent years, COVID-19-era travel restrictions have only exacerbated these issues.
Trial sponsors and clinical research organizations (CROs) face unique challenges when recruiting and maintaining participation in clinical trials. Even greater obstacles exist in trials requiring cross-border travel to participate.
In the Fall issue of the Patients as Partners Newsletter, Scott Gray, CEO discusses the key benefits of engaging patients to improve diversity in clinical trials. When clinical trial stakeholders engage patients they can overcome barriers to participation and alleviate patient uncertainty which improves patients’ experiences and increases retention.
In the August issue of InFocus, Clincierge shares actionable ways to overcome participation barriers for rare diseases. Steps to overcoming participation barriers include coordinating access on a global scale, removing geographic barriers to participation, and leveraging patient coordinators to ensure patient comfort.
The medical community and cultural opinion agree: clinical trials need diversity. It’s our job to serve affected populations, but we cannot do that if we don’t have an appropriate representation of these populations in our research. Minorities are often more at risk for the disease yet are egregiously underrepresented in clinical trials. Understanding why and …
Achieving Clinical Trial Diversity Through Actionable Steps Read More »
Diversity in Clinical Trials: Going Beyond Why to How Diversity is a hot-button issue within the global medical community. The industry continues to seek effective and sustainable solutions to create more diverse clinical trials. Our CEO, Scott Gray, joined Michael Causey, Editor-in-Chief, ACRP TV, to share his insight and practical methods for improving diversity in …
Diversity in Clinical Trials: Going Beyond Why to How Read More »
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
